SGCG and cancer: Type I MAGEs are called cancer-testis antigens (CTAs) because they are primarily expressed in the testis but are normally silent in other tissues; however, they are often aberrantly reactivated during oncogenic transformation and code for antigens recognized by cytotoxic T lymphocytes, and they are also involved in diseases other than cancer, including neurological disorders [70].